IHH Competitors

Delisted . USA . 
Stock . IHH Healthcare Berhad
IHHHFDelisted Stock  USD 1.19  0.00  0.00%   
IHH Healthcare Berhad competes with AMCON Distributing, LithiumBank Resources, Chiba Bank, AmTrust Financial, and Franklin Street; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Care Facilities industry. Analyzing IHH Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of IHH Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of IHH Healthcare competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
1.191.191.19
Details
Intrinsic
Valuation
LowRealHigh
1.011.011.31
Details
Naive
Forecast
LowNextHigh
1.191.191.19
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.191.191.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as IHH Healthcare. Your research has to be compared to or analyzed against IHH Healthcare's peers to derive any actionable benefits. When done correctly, IHH Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in IHH Healthcare Berhad.

IHH Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between IHH Healthcare and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of IHH and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of IHH Healthcare Berhad does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
LBNKF
+ 0.75
DIT
FSP
+ 0.65
AFSIP
CHBAY
+ 0.19
DIT
KEY-PI
+ 0.07
AFSIP
KEY-PI
+ 0.07
FSP
AFSIP
+ 0.04
CHBAY
  
High negative correlations   
AFSIP
- 0.77
LBNKF
FSP
- 0.66
LBNKF
FSP
- 0.59
DIT
AFSIP
- 0.58
DIT
CHBAY
- 0.13
LBNKF
FSP
- 0.12
CHBAY

Risk-Adjusted Indicators

There is a big difference between IHH Pink Sheet performing well and IHH Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IHH Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

IHH Healthcare Competitive Analysis

The better you understand IHH Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, IHH Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across IHH Healthcare's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
IHHHF DIT LBNKF CHBAY AFSIP FSP KEY-PI NIPMY
 0.00 
 1.19 
IHH
 0.56 
 134.07 
AMCON
 4.76 
 0.20 
LithiumBank
 0.00 
 37.68 
Chiba
 2.67 
 14.60 
AmTrust
 1.55 
 1.91 
Franklin
 2.85 
 25.66 
KeyCorp
 0.00 
 17.00 
NIPMY
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Out of control
Very steady
Not too volatile
Very risky
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Weak
Insignificant
Insignificant
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Very Low
Very High
Above Average
Very High
Below Average
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Sell
Not Available
Not Available
Not Available
Hold
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Cautious Hold
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Cautious Hold
Hold
Current Ratio
1.37 X
3.18 X
N/A
N/A
1.62 X
1.35 X
N/A
1.43 X
Net Asset
45.51 B
374.11 M
8.23 M
19.1 T
25.22 B
1.17 B
189.81 B
909.21 B
Profit Margin
0.10 %
0 %
N/A
0.24 %
0.04 %
(0.32) %
0.28 %
0.03 %
EBITDA
4.48 B
27.37 M
(3.47 M)
98.28 B
(284.69 M)
57.93 M
3.6 B
101.17 B
Operating Margin
0.17 %
0.01 %
N/A
0.35 %
(0.07) %
(0.05) %
0.35 %
0.01 %
Current Valuation
13.54 B
254.71 M
19.25 M
(1.71 T)
5.69 B
430.86 M
41.39 B
3.9 B
Price To Book
1.92 X
0.77 X
N/A
0.56 X
N/A
0.30 X
N/A
0.68 X
Retained Earnings
3.37 B
108.55 M
N/A
549.23 B
N/A
(622.65 M)
N/A
291.23 B
Current Asset
4.34 B
89.26 M
N/A
1.88 T
N/A
69.59 M
N/A
368.8 B
Five Year Return
N/A
0.74 %
N/A
2.45 %
11.24 %
6.81 %
N/A
N/A
Beta
0.21
0.54
N/A
0.51
0.62
0.79
1.3
0.48
Number Of Employees
39
1.36 K
3
4.29 K
9.3 K
28
18.21 K
16.19 K
Shares Outstanding
8.81 B
645.46 K
37.17 M
144.92 M
N/A
103.57 M
1.03 B
204.84 M
Cash Flow From Operations
3.53 B
67.87 M
(3.22 M)
710.04 B
(375.3 M)
17.87 M
1.15 B
33.39 B
Annual Yield
0.01 %
0.01 %
N/A
0.04 %
0.12 %
0.02 %
0.06 %
0.03 %
Total Debt
7.61 B
168.84 M
N/A
1.78 T
1.46 B
404.71 M
24.69 B
121.35 B
Return On Equity
0.0754
0.0377
N/A
0.0547
0.0707
-0.059
0.12
0.0445
Z Score
0.6
N/A
N/A
N/A
N/A
N/A
N/A
1.0
Return On Asset
0.0398
0.0305
N/A
0.0031
-0.0108
-0.0021
0.0102
0.0117
Book Value Per Share
2.97 X
177.25 X
N/A
7,165 X
12.60 X
6.42 X
11.74 X
2,404 X
Number Of Shares Shorted
N/A
430
N/A
N/A
N/A
1.7 M
18.87 K
N/A
Current Liabilities
3.65 B
28.9 M
N/A
11.9 T
N/A
58.04 M
N/A
206.06 B
Total Asset
45.51 B
374.11 M
8.23 M
19.1 T
25.22 B
1.17 B
189.81 B
909.21 B
Debt To Equity
0.32 %
1.36 %
N/A
N/A
0.50 %
0.56 %
N/A
0.48 %
Last Dividend Paid
0.06
0.72
N/A
26.0
0.34
0.04
0.79
102.0
Short Ratio
N/A
3.44 X
N/A
N/A
N/A
3.18 X
0.45 X
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
2.0
N/A
N/A
Shares Owned By Institutions
40.52 %
11.19 %
N/A
N/A
N/A
66.89 %
35.36 %
N/A
Market Capitalization
11.84 B
83.29 M
33.6 M
5.53 B
N/A
197.81 M
15.4 B
2.9 B
Price To Earning
224.08 X
10.33 X
N/A
9.33 X
16.38 X
3.69 X
17.11 X
11.34 X
Price To Sales
0.67 X
0.04 X
N/A
0.02 X
N/A
1.56 X
2.02 X
0 X
Net Income
1.86 B
4.34 M
(3.46 M)
54.5 B
(348.89 M)
(48.11 M)
1.92 B
48.05 B
Earnings Per Share
0.05 X
6.71 X
N/A
2.58 X
0.98 X
(0.40) X
2.48 X
1.29 X
Shares Owned By Insiders
51.78 %
73.01 %
13.46 %
N/A
N/A
24.49 %
N/A
N/A
Revenue
17.13 B
2.71 B
N/A
207.76 B
5.82 B
145.71 M
7.03 B
1.17 T
Working Capital
691 M
135.83 M
N/A
(10.02 T)
N/A
201.91 M
N/A
162.75 B
Cash And Equivalents
4.47 B
600.94 K
N/A
3.81 T
756.1 M
3.74 M
2.63 B
107.35 B
Cash Per Share
0.51 X
1.03 X
N/A
N/A
3.82 X
0.10 X
2.62 X
524.45 X
Gross Profit
6 B
127.72 M
N/A
213.48 B
872.65 M
78.17 M
6.74 B
200.03 B
Day Typical Price
1.19
134.07
0.2
37.68
14.6
1.9
25.42
17.0
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
0.0464
0.03
N/A
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
0.09
0.77
N/A
Daily Balance Of Power
0.0
(9,223,372,036,855)
(9,223,372,036,855)
0.0
(9,223,372,036,855)
(0.33)
0.9221
0.0
Period Momentum Indicator
N/A
(0.75)
(0.01)
N/A
(0.40)
(0.03)
0.71
N/A
Rate Of Daily Change
1.0
0.99
0.95
1.0
0.97
0.98
1.03
1.0
Day Median Price
1.19
134.07
0.2
37.68
14.6
1.9
25.3
17.0
Price Action Indicator
N/A
(0.37)
(0.01)
N/A
(0.20)
N/A
0.72
N/A
Coefficient Of Variation
N/A
30807.55
(508.70)
3161.11
1326.98
1616.06
1104.99
N/A
Mean Deviation
N/A
2.41
3.49
0.2075
0.9628
2.23
0.5966
N/A
Jensen Alpha
N/A
(0.12)
(0.83)
0.0188
0.0835
(0.0002)
0.0481
N/A
Total Risk Alpha
N/A
(0.60)
(1.62)
(0.14)
(0.14)
(0.32)
(0.07)
N/A
Sortino Ratio
N/A
(0.03)
N/A
N/A
(0.02)
0.0174
(0.09)
N/A
Downside Variance
N/A
13.28
N/A
N/A
3.29
7.22
0.5303
N/A
Standard Deviation
N/A
3.62
4.43
0.964
1.45
2.98
0.8179
N/A
Kurtosis
N/A
1.68
(0.26)
32.64
1.13
0.997
1.7
N/A
Potential Upside
N/A
7.69
6.67
N/A
2.71
4.62
1.43
N/A
Treynor Ratio
N/A
0.0018
2.27
1.59
0.814
0.1275
0.5134
N/A
Maximum Drawdown
N/A
20.23
18.77
10.86
7.09
12.58
4.04
N/A
Variance
N/A
13.09
19.6
0.9293
2.09
8.88
0.6689
N/A
Market Risk Adjusted Performance
N/A
0.0118
2.28
1.6
0.824
0.1375
0.5234
N/A
Risk Adjusted Performance
N/A
0.0104
(0.14)
0.0263
0.0623
0.0547
0.0698
N/A
Skewness
N/A
0.2419
0.0153
1.6
(0.32)
0.7509
0.6581
N/A
Semi Deviation
N/A
3.03
N/A
N/A
1.31
2.41
0.6028
N/A
Information Ratio
N/A
(0.03)
(0.23)
(0.11)
(0.02)
0.0157
(0.08)
N/A
Value At Risk
N/A
(5.43)
(8.70)
N/A
(2.67)
(4.22)
(1.02)
N/A
Expected Short fall
N/A
(3.47)
N/A
N/A
(1.07)
(2.64)
(0.69)
N/A
Downside Deviation
N/A
3.64
N/A
N/A
1.82
2.69
0.7282
N/A
Semi Variance
N/A
9.16
N/A
N/A
1.72
5.79
0.3633
N/A

IHH Healthcare Competition Performance Charts

Five steps to successful analysis of IHH Healthcare Competition

IHH Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by IHH Healthcare Berhad in relation to its competition. IHH Healthcare's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of IHH Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact IHH Healthcare's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to IHH Healthcare Berhad, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your IHH Healthcare position

In addition to having IHH Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cannabis Thematic Idea Now

Cannabis
Cannabis Theme
Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. The Cannabis theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cannabis Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in IHH Pink Sheet

If you are still planning to invest in IHH Healthcare Berhad check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IHH Healthcare's history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY